Company / R&D per Share
Zentalis Pharmaceuticals, Inc. R&D per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$2.66
FY2025
5-year range
$2.44 / $2.66
FY2024-FY2025
Trend
+9.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
2.66 in FY2025.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share increased 9.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.66 | +9.0% |
| FY2024 | $2.44 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026